Medicus Pharma Ltd (MDCX) Q3 2026 Earnings Call Highlights: Pfizer ADC License, SkinJet SPAC ...
Medicus Pharma Ltd (MDCX) outlined its CD228V license from Pfizer, a proposed $135 million SkinJet SPAC combination and a $35.9 million nine-month net loss amid tight liquidity. Related Stocks: MDCX ,